Google DeepMind's Co-Scientist Helps Identify Repurposed Drugs for Liver Fibrosis

Jul 10, 2026

A Stanford geneticist used Google DeepMind's Co-Scientist system to help identify potential repurposed medicines for liver fibrosis. The AI tool analyzed biomedical data to suggest existing drugs that could be effective against chronic liver disease.

Why it matters: This demonstrates how AI can accelerate drug repurposing for diseases with limited treatment options.

Full story at: Google DeepMind ↗